PubMed pubmed.ncbi.nlm.nih.gov [46] GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity PubMed pubmed.ncbi.nlm.nih.gov [47] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [48] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [49] GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations PubMed pubmed.ncbi.nlm.nih.gov [50] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [51] Adverse Effects of GLP-1 Receptor Agonists PubMed pubmed.ncbi.nlm.nih.gov [52] Use of glucagon-like-peptide 1 receptor agonist in the treatment of childhood obesity PubMed pubmed.ncbi.nlm.nih.gov [53] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point
The common side effects of retatrutide are: Nausea Vomiting Diarrhea Constipation Fatigue Abdominal discomfort Early satiety Injection site reactions Increased heart rate Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Liver problems Severe gastrointestinal issues Major depressive disorder Suicidal ideal Changes in mood and behavior Pancreatitis Low blood sugar levels (hypoglycemia) Cardiac arrhythmias The drug is still not FDA-approved and contraindications have not yet been determined
Water, Butylene Glycol, Cetyl Ethylhexanoate, Niacinamide, Helianthus Annuus (Sunflower) Seed Oil, Glycerin, Ethylhexyl Palmitate, Tranexamic Acid, Polyglyceryl-2 Dipolyhydroxystearate, Cyclopentasiloxane, 1,2-Hexanediol, Sodium Chloride, Sorbitan Sesquioleate, Dipropylene Glycol, Panthenol, Glutathione, Disteardimonium Hectorite, Maltodextrin, Hippophae Rhamnoides (Sea Buckthorn) Fruit Oil, Phosphatidylcholine, Ethyl Ascorbyl Ether, Polyglyceryl-10 Laurate, Propylene Carbonate, Diospyros Kaki (Persimmon) Extract, Adenosine, Hydrolyzed Collagen, Linum Usitatissimum (Linseed) Seed Extract, Ascorbic Acid, Tocopheryl Acetate, Thioctic Acid, Camellia Japonica Flower Extract, Centella Asiatica Leaf Extract, Houttuynia Cordata Extract, Paeonia Lactiflora Root Extract, Solanum Lycopersicum (Tomato) Fruit Extract, Ubiquinone, Polysorbate 20, Lecithin, SH-Oligopeptide-1
Global analyses similarly indicate that GLP-1 RAs remain substantially more accessible in diabetes care than in obesity care, reflecting reimbursement structures, variable professional familiarity, and weight-related biases in clinical pathways [88]
